{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T16:36:52Z","timestamp":1763743012192,"version":"3.45.0"},"reference-count":20,"publisher":"BMJ","issue":"4","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Clin Pathol"],"accepted":{"date-parts":[[2020,3,21]]},"published-print":{"date-parts":[[2021,4]]},"abstract":"<jats:sec>\n                    <jats:title>Aim<\/jats:title>\n                    <jats:p>The prognostic significance of perineural invasion (PNI) in oesophageal adenocarcinoma (EAC) is unclear. We examined the association of PNI with clinical outcomes in patients treated with neoadjuvant chemoradiotherapy (nCRT) and surgery.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We performed a single institutional retrospective study. We evaluated the association of PNI with locoregional recurrence-free survival (LRFS), distant metastasis-free survival, disease-free survival (DFS) and overall survival using log-rank and Cox proportional hazard modelling.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>29 out of 73 patients (40%) had PNI at the time of surgery. The median follow-up was 20.1 months. The median DFS was 18.4 months for patients with PNI vs 41.3 months for patients without PNI (p&lt;0.05). The median LRFS was 23.3 months for patients with PNI and median not reached for patients without PNI (p&lt;0.01). In a multivariate model including age and pathological variables, PNI remained a significant independent predictor of LRFS (HR 0.20, 95% CI 0.07 to 0.60; p=0.004).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>For patients with EAC treated with nCRT, PNI found at the time of surgery is significantly associated with worse LRFS. Our data support attempts to validate this finding and perhaps testing the role of adjuvant therapy in patients with PNI.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/jclinpath-2020-206424","type":"journal-article","created":{"date-parts":[[2020,4,21]],"date-time":"2020-04-21T17:19:41Z","timestamp":1587489581000},"page":"228-233","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":2,"title":["Perineural invasion predicts for locoregional failure in patients with oesophageal adenocarcinoma treated with neoadjuvant chemoradiotherapy"],"prefix":"10.1136","volume":"74","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2961-9304","authenticated-orcid":false,"given":"Ankur K","family":"Patel","sequence":"first","affiliation":[{"name":"Department of Radiation Oncology, Ohio State University James Cancer Hospital, Columbus, Ohio, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xueliang","family":"Pan","sequence":"additional","affiliation":[{"name":"Department of Biomedical Informatics, Ohio State University College of Medicine, Columbus, Ohio, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diana M","family":"Vila","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Ohio State University James Cancer Hospital, Columbus, Ohio, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wendy L","family":"Frankel","sequence":"additional","affiliation":[{"name":"Department of Pathology, Ohio State University Wexner Medical Center, Columbus, Ohio, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Pathology, Ohio State University Wexner Medical Center, Columbus, Ohio, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyle A","family":"Perry","sequence":"additional","affiliation":[{"name":"Division of General and Gastrointestinal Surgery, Ohio State University Wexner Medical Center, Columbus, Ohio, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert E","family":"Merritt","sequence":"additional","affiliation":[{"name":"Division of Thoracic Surgery, Ohio State University Wexner Medical Center, Columbus, Ohio, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Desmond M","family":"D'Souza","sequence":"additional","affiliation":[{"name":"Division of Thoracic Surgery, Ohio State University Wexner Medical Center, Columbus, Ohio, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evan J","family":"Wuthrick","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Ohio State University James Cancer Hospital, Columbus, Ohio, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Terence M","family":"Williams","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Ohio State University James Cancer Hospital, Columbus, Ohio, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2020,4,21]]},"reference":[{"key":"2025112108333256000_74.4.228.1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.29210"},{"key":"2025112108333256000_74.4.228.2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.12.9593"},{"key":"2025112108333256000_74.4.228.3","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(07)70039-6"},{"key":"2025112108333256000_74.4.228.4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1112088"},{"key":"2025112108333256000_74.4.228.5","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.24396"},{"key":"2025112108333256000_74.4.228.6","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1177\/000348948509400420","article-title":"Nerves and neurotropic carcinomas","volume":"94","author":"Batsakis","year":"1985","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"2025112108333256000_74.4.228.7","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0142(19990201)85:3<520::AID-CNCR2>3.0.CO;2-L"},{"key":"2025112108333256000_74.4.228.8","doi-asserted-by":"publisher","DOI":"10.1097\/00000478-199502000-00007"},{"key":"2025112108333256000_74.4.228.9","doi-asserted-by":"crossref","first-page":"9282","DOI":"10.3748\/wjg.v19.i48.9282","article-title":"Refining pathological evaluation of neoadjuvant therapy for adenocarcinoma of the esophagus","volume":"19","author":"Noble","year":"2013","journal-title":"World J Gastroenterol"},{"key":"2025112108333256000_74.4.228.10","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6600252"},{"key":"2025112108333256000_74.4.228.11","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s12253-017-0253-z","article-title":"Histopathologic features are more important prognostic factors than primary tumour location in gastro-oesophageal adenocarcinoma treated with preoperative chemoradiation and surgery","volume":"24","author":"Vo\u0161mik","year":"2018","journal-title":"Pathol Oncol Res"},{"key":"2025112108333256000_74.4.228.12","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-14-313"},{"key":"2025112108333256000_74.4.228.13","first-page":"961","article-title":"Pathologic prognostic factors in esophageal squamous cell carcinoma: a follow-up study of 74 patients with or without preoperative chemoradiation therapy","volume":"12","author":"Torres","year":"1999","journal-title":"Mod Pathol"},{"key":"2025112108333256000_74.4.228.14","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1038\/bjc.2015.354","article-title":"The presence of lymphovascular and perineural infiltration after neoadjuvant therapy and oesophagectomy identifies patients at high risk for recurrence","volume":"113","author":"Lagarde","year":"2015","journal-title":"Br J Cancer"},{"key":"2025112108333256000_74.4.228.15","first-page":"1467","article-title":"Prognostic impact of perineural, blood and lymph vessel invasion for esophageal cancer","volume":"29","author":"Tachezy","year":"2014","journal-title":"Histol Histopathol"},{"key":"2025112108333256000_74.4.228.16","doi-asserted-by":"publisher","DOI":"10.1002\/bjs.4778"},{"key":"2025112108333256000_74.4.228.17","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2015.04.053"},{"key":"2025112108333256000_74.4.228.18","doi-asserted-by":"publisher","DOI":"10.1002\/jso.21784"},{"key":"2025112108333256000_74.4.228.19","doi-asserted-by":"crossref","first-page":"303","DOI":"10.3109\/0284186X.2015.1110252","article-title":"Patterns and predictors of failure following tri-modality therapy for locally advanced esophageal cancer","volume":"55","author":"Shaikh","year":"2016","journal-title":"Acta Oncol"},{"key":"2025112108333256000_74.4.228.20","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1056\/NEJMoa1805101","article-title":"Hybrid minimally invasive esophagectomy for esophageal cancer","volume":"380","author":"Mariette","year":"2019","journal-title":"N Engl J Med"}],"container-title":["Journal of Clinical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jclinpath-2020-206424","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T16:33:39Z","timestamp":1763742819000},"score":1,"resource":{"primary":{"URL":"https:\/\/jcp.bmj.com\/lookup\/doi\/10.1136\/jclinpath-2020-206424"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,21]]},"references-count":20,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2021,3,18]]},"published-print":{"date-parts":[[2021,4]]}},"alternative-id":["10.1136\/jclinpath-2020-206424"],"URL":"https:\/\/doi.org\/10.1136\/jclinpath-2020-206424","relation":{},"ISSN":["0021-9746","1472-4146"],"issn-type":[{"type":"print","value":"0021-9746"},{"type":"electronic","value":"1472-4146"}],"subject":[],"published":{"date-parts":[[2020,4,21]]}}}